Forlani, Gabriele

Nonalcoholic Fatty Liver Disease

Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 2,581

Obesity-Associated Liver Disease

Marchesini, G., Moscatiello, S., Di Domizio, S., & Forlani, G. (2008) · The Journal of Clinical Endocrinology & Metabolism

Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects

Cited by 359

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

Vaccaro, O., Masulli, M., Nicolucci, A., Bonora, E., Del Prato, S., Maggioni, A. P., Rivellese, A. A., Squatrito, S., Giorda, C. B., Sesti, G., et al. (2017) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 292

Effects of cognitive–behavioural therapy on health-related quality of life in obese subjects with and without binge eating disorder

Marchesini, G., Natale, S., Chierici, S., Manini, R., Besteghi, L., Di Domizio, S., Sartini, A., Pasqui, F., Baraldi, L., Forlani, G., et al. (2002) · International Journal of Obesity

Eating Disorders and BehaviorsObesity, Physical Activity, Diet

Cited by 58

Are severe hypoglycemic episodes in diabetes correctly identified by administrative data? Evidence of underreporting from the HYPOTHESIS study

The Italian Society of Emergency Medicine (SIMEU), Veronese, G., Marchesini, G., Forlani, G., & Fabbri, A. (2016) · Acta Diabetologica

Diabetes Management and ResearchMedical Coding and Health Information

Cited by 7